Icure Pharmaceutical Incorporation
A biopharmaceutical firm specializing in Transdermal Drug Delivery System technology.
175250 | KO
Overview
Corporate Details
- ISIN(s):
- KR7175250000
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 강남구 봉은사로104길 10 7층, 강남구
- Website:
- https://www.icure.co.kr/eng/
- Sector:
- Manufacturing
Description
Icure Pharmaceutical Incorporation is a biopharmaceutical company that researches, develops, manufactures, and commercializes high-tech drug products. The company's core expertise lies in its Transdermal Drug Delivery System (TDDS) technology, which facilitates 'Cure & Care' solutions through the skin. Its portfolio includes both pharmaceutical products, such as NSAIDS patches, and cosmetic lines developed with a pharmaceutical and medical foundation. Icure focuses on creating innovative formulations and drug delivery systems to improve therapeutic outcomes and patient convenience.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-17 00:00 |
기타시장안내 (상장적격성 실질심사 대상 결정)
|
Korean | 4.9 KB | ||
| 2025-09-17 00:00 |
주권매매거래정지기간변경 (상장적격성 실질심사 대상 결정)
|
Korean | 4.7 KB | ||
| 2025-09-16 00:00 |
주요사항보고서(자기전환사채만기전취득결정)
|
Korean | 14.7 KB | ||
| 2025-08-27 00:00 |
기타시장안내 (실질심사 대상여부 결정을 위한 조사기간 연장 안내)
|
Korean | 3.2 KB | ||
| 2025-08-22 00:00 |
주요사항보고서(자기전환사채만기전취득결정)
|
Korean | 14.7 KB | ||
| 2025-08-22 00:00 |
[기재정정]주요사항보고서(전환사채권발행결정)
|
Korean | 85.9 KB | ||
| 2025-08-14 00:00 |
[기재정정]사업보고서 (2024.12)
|
Korean | 2.6 MB | ||
| 2025-08-14 00:00 |
반기보고서 (2025.06)
|
Korean | 1.8 MB | ||
| 2025-08-05 00:00 |
횡령ㆍ배임혐의발생
|
Korean | 8.7 KB | ||
| 2025-08-05 00:00 |
주권매매거래정지 (상장적격성 실질심사 대상 (사유발생))
|
Korean | 4.6 KB | ||
| 2025-08-05 00:00 |
기타시장안내 (상장적격성 실질심사 관련 안내)
|
Korean | 2.7 KB | ||
| 2025-08-05 00:00 |
기타시장안내 (상장적격성 실질심사 대상결정 기한 안내)
|
Korean | 3.0 KB | ||
| 2025-07-16 00:00 |
[기재정정]주요사항보고서(전환사채권발행결정)
|
Korean | 79.1 KB | ||
| 2025-07-10 00:00 |
주식등의대량보유상황보고서(약식)
|
Korean | 66.8 KB | ||
| 2025-06-30 00:00 |
전환사채(해외전환사채포함)발행후만기전사채취득
|
Korean | 9.0 KB |
Automate Your Workflow. Get a real-time feed of all Icure Pharmaceutical Incorporation filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Icure Pharmaceutical Incorporation
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Icure Pharmaceutical Incorporation via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
